✦ LIBER ✦

Differential regulation of apolipoprotein E expression by estrogen receptor A and B isoform-selective ligands: Estrogen receptor selective hormone therapy

✍ Scribed by Jun Ming Wang; Roberta D. Brinton

Book ID: 118461877
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 49 KB
Volume: 1
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2005.06.248

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of progesterone receptor isof

Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines

✍ Annika Vienonen; Heimo Syvälä; Susanna Miettinen; Pentti Tuohimaa; Timo Ylikomi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Direct regulation of microRNA biogenesis

Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer

✍ Paris, O; Ferraro, L; Grober, O M V; Ravo, M; De Filippo, M R; Giurato, G; Nassa 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 949 KB

Differential Expression of the A and B I

Differential Expression of the A and B Isoforms of Progesterone Receptor in Human Endometrial Cancer Cells : Only Progesterone Receptor B Is Induced by Estrogen and Associated with Strong Transcriptional Activation

✍ KIMBERLY K. LESLIE; NIRMALA S. KUMAR; JENNIFER RICHER; GARETH OWEN; GLENN TAKIMO 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Nuclear estrogen receptor targeted photo

Nuclear estrogen receptor targeted photodynamic therapy: Selective uptake and killing of MCF-7 breast cancer cells by a C17α-alkynylestradiol-porphyrin conjugate

✍ Narasimha Swamy; Ajay Purohit; Ana Fernandez-Gacio; Graham B. Jones; Rahul Ray 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

## Abstract We hypothesized that over‐expression of estrogen receptor (ER) in hormone‐sensitive breast cancer could be harnessed synergistically with the tumor‐migrating effect of porphyrins to selectively deliver estrogen‐porphyrin conjugates into breast tumor cells, and preferentially kill the tu